Advisory Committee on Immunization Practices (ACIP), 5812 [2013-01649]

Download as PDF 5812 Federal Register / Vol. 78, No. 18 / Monday, January 28, 2013 / Notices Financial Administrative Services, Office of the Director, Agency for Toxic Substances and Disease Registry. Section T–B, Organization and Functions, is hereby amended as follows: Delete in its entirety the title for the Office of Financial and Administrative Services (JAA2), Office of the Director (JAA), Agency for Toxic Substances and Disease Registry (JA) and insert the title Office of Financial, Administrative, and Information Services (JAA2), Office of the Director (JAA), Agency for Toxic Substances and Disease Registry (JA). Revise the functional statement for the Office of Financial, Administrative, and Information Services (JAA2), as follows: After item (6), insert the following item: (7) enables and supports NCEH/ ATSDR data management, systems development, and information security needs. Dated: January 11, 2013. Sherri A. Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2013–01663 Filed 1–25–13; 8:45 am] BILLING CODE 4160–70–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting of the aforementioned committee: tkelley on DSK3SPTVN1PROD with Times and Dates 8:00 a.m.–5:00 p.m., February 20, 2013, 8:00 a.m.–3:00 p.m., February 21, 2013. Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road, NE., Building 19, Kent ‘‘Oz’’ Nelson Auditorium, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with VerDate Mar<15>2010 17:13 Jan 25, 2013 Jkt 229001 schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Further, under provisions of the Affordable Care Act, at section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been adopted by the Director of the Centers for Disease Control and Prevention must be covered by applicable health plans. Matters To Be Discussed: The agenda will include discussions on: adult immunization, general recommendations, 13-valent pneumococcal conjugate vaccine, influenza, Japanese encephalitis vaccine, pertussis, Haemophilus influenzae b (Hib) vaccine, smallpox and vaccine supply. Recommendation votes are scheduled for Hib vaccine, influenza and 13-valent pneumococcal conjugate vaccine. VFC votes are scheduled for Haemophilus influenzae b (Hib) vaccine and 13-valent pneumococcal conjugate vaccine. Time will be available for public comment. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Stephanie B. Thomas, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., MS–A27, Atlanta, Georgia 30333, Telephone: (404) 639–8836; Email ACIP@CDC.GOV. Meeting is Web cast live via the World Wide Web; for instructions and more information on ACIP please visit the ACIP Web site: https://www.cdc.gov/ vaccines/acip/. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: January 22, 2013. Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–01649 Filed 1–25–13; 8:45 am] Frm 00042 Fmt 4703 Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 77 FR 65390, dated October 26, 2012) is amended to reflect the reorganization of the Office of the Director, National Center for Environmental Health, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: Delete in its entirety the title Office of Financial and Administrative Services (CUG14), Office of the Director (CUG1), National Center for Environmental Health (CUG) and insert the title Office of Financial, Administrative, and Information Services (CUG14), Office of the Director (CUG1), National Center for Environmental Health (CUG). Revise the functional statement for the Office of Financial, Administrative, and Information Services (CUG14), as follows: After item (6), insert the following item: (7) enables and supports NCEH/ ATSDR data management, systems development, and information security needs. Dated: January 11, 2013. Sherri A. Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2013–01660 Filed 1–25–13; 8:45 am] BILLING CODE 4160–18–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Proposed Information Collection Activity; Comment Request Proposed Projects Title: Federal Tax Offset, Administrative Offset, and Passport Denial. OMB No.: 0970–0161. The Federal Tax Offset, Administrative Offset, and Passport Denial programs collect past-due child BILLING CODE 4160–18–P PO 00000 DEPARTMENT OF HEALTH AND HUMAN SERVICES Sfmt 4703 E:\FR\FM\28JAN1.SGM 28JAN1

Agencies

[Federal Register Volume 78, Number 18 (Monday, January 28, 2013)]
[Notices]
[Page 5812]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01649]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee:

Times and Dates

    8:00 a.m.-5:00 p.m., February 20, 2013, 8:00 a.m.-3:00 p.m., 
February 21, 2013.
    Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton 
Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia 
30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, CDC, 
on the appropriate uses of immunizing agents. In addition, under 42 
U.S.C. 1396s, the committee is mandated to establish and periodically 
review and, as appropriate, revise the list of vaccines for 
administration to vaccine-eligible children through the Vaccines for 
Children (VFC) program, along with schedules regarding the appropriate 
periodicity, dosage, and contraindications applicable to the vaccines. 
Further, under provisions of the Affordable Care Act, at section 2713 
of the Public Health Service Act, immunization recommendations of the 
ACIP that have been adopted by the Director of the Centers for Disease 
Control and Prevention must be covered by applicable health plans.
    Matters To Be Discussed: The agenda will include discussions on: 
adult immunization, general recommendations, 13-valent pneumococcal 
conjugate vaccine, influenza, Japanese encephalitis vaccine, pertussis, 
Haemophilus influenzae b (Hib) vaccine, smallpox and vaccine supply. 
Recommendation votes are scheduled for Hib vaccine, influenza and 13-
valent pneumococcal conjugate vaccine. VFC votes are scheduled for 
Haemophilus influenzae b (Hib) vaccine and 13-valent pneumococcal 
conjugate vaccine. Time will be available for public comment. Agenda 
items are subject to change as priorities dictate.
    Contact Person for More Information: Stephanie B. Thomas, National 
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton 
Road, NE., MS-A27, Atlanta, Georgia 30333, Telephone: (404) 639-8836; 
Email ACIP@CDC.GOV.
    Meeting is Web cast live via the World Wide Web; for instructions 
and more information on ACIP please visit the ACIP Web site: https://www.cdc.gov/vaccines/acip/.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

    Dated: January 22, 2013.
Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2013-01649 Filed 1-25-13; 8:45 am]
BILLING CODE 4160-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.